The weekly litigation news digest is live. Subscribe now

IP Verse

Lyophilized Preparation Of Botulinum Toxin - EP2692350

The patent EP2692350 was granted to Medy TOX on Jun 28, 2023. The application was filed on Mar 30, 2012 under application number EP12765216A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2692350

MEDY TOX
Application Number
EP12765216A
Filing Date
Mar 30, 2012
Status
Patent Maintained As Amended
May 26, 2023
Publication Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
IPSEN PHARMAFeb 2, 2018PLASSERAUDADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONKR20090005963
INTERNATIONAL-SEARCH-REPORTKR20060028475
INTERNATIONAL-SEARCH-REPORTKR20080052510
INTERNATIONAL-SEARCH-REPORTKR20090005963
INTERNATIONAL-SEARCH-REPORTUS7829525
OPPOSITIONUS2003118598
OPPOSITIONUS2007134199
OPPOSITIONWO0158472
OPPOSITIONWO2006005910
OPPOSITIONWO2007041664
OPPOSITIONWO2009008595
OPPOSITIONWO2010118888
OPPOSITIONWO9735604
SEARCHGB2416122
SEARCHUS2010279953
SEARCHWO9735604

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents